Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus

A L Moyne1, R Shelby, T E Cleveland

  • 1Department of Entomology and Plant Pathology, 209 Life Sciences Building, Auburn University, Auburn, AL 36849, USA. amoyne@acesag.auburn.edu

Abstract

Insights

Bacillus subtilis AU195 produces two antifungal bacillomycin D analogues effective against Aspergillus flavus. These lipopeptides, differing in lipid chain length, show potent antifungal activity, highlighting their potential in agricultural and medical applications.

Area of Science:

  • Microbiology
  • Biochemistry
  • Natural Product Chemistry

Background:

  • Aspergillus flavus poses a significant threat to agriculture and human health.
  • Antifungal peptides are a promising alternative to conventional antifungal agents.
  • Bacillus subtilis is known to produce various bioactive compounds, including antimicrobial peptides.

Purpose of the Study:

  • To isolate and identify antifungal peptides from Bacillus subtilis AU195 with high activity against Aspergillus flavus.
  • To characterize the chemical structure and antifungal properties of the purified compounds.

Main Methods:

  • Screening of Bacillus subtilis isolates for antagonistic activity against Aspergillus flavus.
  • Protein purification using anion exchange and gel filtration chromatography.
  • Mass spectrometry for molecular weight determination and structural analysis.

Main Results:

  • Two lipopeptides with antifungal activity against Aspergillus flavus were purified from Bacillus subtilis AU195.
  • The purified lipopeptides were identified as bacillomycin D analogues with masses of 1045 and 1059 m/z.
  • The mass difference of 14 units was attributed to variations in the lipid chain length (C15 vs. C16).

Conclusions:

  • Bacillus subtilis AU195 synthesizes a mixture of two bacillomycin D analogues with distinct lipid chain lengths.
  • Both analogues demonstrated potent activity against Aspergillus flavus at similar concentrations.
  • Lipid chain length influenced the activity of these lipopeptides against other fungal species.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...